132 related articles for article (PubMed ID: 25941957)
1. Testosterone nasal gel (Natesto) for hypogonadism.
Med Lett Drugs Ther; 2015 May; 57(1468):73-4. PubMed ID: 25941957
[TBL] [Abstract][Full Text] [Related]
2. Natesto™ , a novel testosterone nasal gel, normalizes androgen levels in hypogonadal men.
Rogol AD; Tkachenko N; Bryson N
Andrology; 2016 Jan; 4(1):46-54. PubMed ID: 26695758
[TBL] [Abstract][Full Text] [Related]
3. Effect of Natesto on Reproductive Hormones, Semen Parameters and Hypogonadal Symptoms: A Single Center, Open Label, Single Arm Trial.
Ramasamy R; Masterson TA; Best JC; Bitran J; Ibrahim E; Molina M; Kaiser UB; Miao F; Reis IM
J Urol; 2020 Sep; 204(3):557-563. PubMed ID: 32294396
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of transdermal testosterone gel in hypogonadal men: application of gel at one site versus four sites: a General Clinical Research Center Study.
Wang C; Berman N; Longstreth JA; Chuapoco B; Hull L; Steiner B; Faulkner S; Dudley RE; Swerdloff RS
J Clin Endocrinol Metab; 2000 Mar; 85(3):964-9. PubMed ID: 10720024
[TBL] [Abstract][Full Text] [Related]
5. Testosterone therapy--what, when and to whom?
Jockenhövel F
Aging Male; 2004 Dec; 7(4):319-24. PubMed ID: 15799128
[TBL] [Abstract][Full Text] [Related]
6. The long-term efficacy and safety of a testosterone mucoadhesive buccal tablet in testosterone-deficient men.
Dinsmore WW; Wyllie MG
BJU Int; 2012 Jul; 110(2):162-9. PubMed ID: 22288877
[TBL] [Abstract][Full Text] [Related]
7. Transdermal testosterone gel: pharmacokinetics, efficacy of dosing and application site in hypogonadal men.
Meikle AW; Matthias D; Hoffman AR
BJU Int; 2004 Apr; 93(6):789-95. PubMed ID: 15049991
[TBL] [Abstract][Full Text] [Related]
8. Testosterone supplementation for hypogonadal men by the nasal route.
Mattern C; Hoffmann C; Morley JE; Badiu C
Aging Male; 2008 Dec; 11(4):171-8. PubMed ID: 19172548
[TBL] [Abstract][Full Text] [Related]
9. The current status of therapy for symptomatic late-onset hypogonadism with transdermal testosterone gel.
Ebert T; Jockenhövel F; Morales A; Shabsigh R
Eur Urol; 2005 Feb; 47(2):137-46. PubMed ID: 15661407
[TBL] [Abstract][Full Text] [Related]
10. Testosterone gel shows promise in Phase III trial.
AIDS Alert; 1999 Jun; 14(6):67. PubMed ID: 11366410
[TBL] [Abstract][Full Text] [Related]
11. Testim 1% testosterone gel for the treatment of male hypogonadism.
Bouloux P
Clin Ther; 2005 Mar; 27(3):286-98. PubMed ID: 15878382
[TBL] [Abstract][Full Text] [Related]
12. Testosterone treatment comes of age: new options for hypogonadal men.
Nieschlag E
Clin Endocrinol (Oxf); 2006 Sep; 65(3):275-81. PubMed ID: 16918944
[TBL] [Abstract][Full Text] [Related]
13. Optimal diagnostic measures and thresholds for hypogonadism in men with HIV/AIDS: comparison between 2 transdermal testosterone replacement therapy gels.
Blick G
Postgrad Med; 2013 Mar; 125(2):30-9. PubMed ID: 23816769
[TBL] [Abstract][Full Text] [Related]
14. A novel testosterone 2% gel for the treatment of hypogonadal males.
Dobs AS; McGettigan J; Norwood P; Howell J; Waldie E; Chen Y
J Androl; 2012; 33(4):601-7. PubMed ID: 21979302
[TBL] [Abstract][Full Text] [Related]
15. A new testosterone gel (fortesta) for hypogonadism.
Med Lett Drugs Ther; 2011 Apr; 53(1362):29-30. PubMed ID: 21502933
[TBL] [Abstract][Full Text] [Related]
16. A practical guide to male hypogonadism in the primary care setting.
Dandona P; Rosenberg MT
Int J Clin Pract; 2010 May; 64(6):682-96. PubMed ID: 20518947
[TBL] [Abstract][Full Text] [Related]
17. Testosterone topical solution (Axiron) for hypogonadism.
Med Lett Drugs Ther; 2011 Jul; 53(1368):54-5. PubMed ID: 21738108
[TBL] [Abstract][Full Text] [Related]
18. Testosterone supplementation: what and how to give.
Jockenhövel F
Aging Male; 2003 Sep; 6(3):200-6. PubMed ID: 14628500
[TBL] [Abstract][Full Text] [Related]
19. Transdermal delivery of testosterone.
Hadgraft J; Lane ME
Eur J Pharm Biopharm; 2015 May; 92():42-8. PubMed ID: 25709060
[TBL] [Abstract][Full Text] [Related]
20. Testosterone replacement therapy.
Jones TH
Br J Hosp Med (Lond); 2007 Oct; 68(10):547-53. PubMed ID: 17974303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
